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Abstract
Mononuclear cells from bone marrow have been used in various treatments of diseases in an attempt to regenerate 
tissues. The objective of this study was to evaluate the accession and proliferation of mononuclear cells in a critical 
defect, with the addition of platelet-rich plasma (PRP) and / or TGF-β1 (transforming growth factor beta 1), and 
then to evaluate bone repair at defective sites on the femurs of rats. We created a critical defect on the bilateral femurs 
of 33 Wistar-Kyoto rats. Mononuclear bone marrow cells, TGF-β and PRP were added to the lesion on the treated 
side and saline on the contralateral side. We determined the adhesion of mononuclear cells at the critical defect and 
bone repair. The presence and consequent adhesion of the mononuclear cells administered to the treated animals 
was not demonstrated by PCR. Radiographic analysis showed closure of the lesion, but we could not affirm that this 
resulted from the treatments administered or by normal bone regeneration itself, when the lesion was evaluated at 
6 and 10 weeks postoperative, seeing that there were no significant differences between the groups. Conclusions: a) 
Bone marrow mononuclear cells did not adhere at the critical defect created in the rat femur; b) It was not possible 
to determine the efficiency of the bone repair treatments studied, as the results did not show significant differences 
between the groups. 
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Resumo 
As células mononucleares da medula óssea têm sido utilizadas em diversas afecções na tentativa de regeneração 
tecidual. O objetivo deste estudo foi o de avaliar a adesão das células mononucleares sobre defeito crítico, com a 
adição do plasma rico em plaquetas PRP) e / ou TGF-β1 (Fator de crescimento transformador Beta 1), e, por fim, 
verificar o reparo ósseo dos sítios defeituosos dos fêmures dos ratos.  Foi criado um defeito bilateral critico nos 
fêmures de 33 Wistar-Kyoto ratos. Células mononucleares de medula óssea, TGF-β e PRP foram adicionadas no lado 
tratado da lesão e soro fisiológico no lado contralateral. Determinou-se a adesão de células mononucleares sobre 
o defeito crítico e reparo ósseo. A presença e consequente adesão das células mononucleares administradas nos 
animais tratados não foi  evidenciada através da técnica de  PCR. As análises radiológicas evidenciam fechamento da 
lesão, porém, nós não podemos afirmar que foi pelos  tratamentos administrados ou pela própria regeneração óssea, 
quando analisadas em seis e 10 semanas pós-operatórias, haja visto não apresentarem diferenças significantes entre 
os grupos. Conclusões: a) As células mononucleares não aderiram ao defeito crítico criado no fêmur do rato; b) Não 
foi possível avaliar  a eficiência dos tratamentos propostos para  o reparo ósseo, por não apresentarem diferenças 
significativas  entre os grupos. 
Palavras-chaves: Defeito crítico. Fêmur. PRP. TGF-β1.Ratos.
Introduction
The possibility of the regeneration of tissues and organs 
has been the subject of research over the years. Thus, new 
areas of medicine are investigating techniques for tissue 
regeneration from natural regulators (growth factors) and 
components of the organism itself (stem cells)1 .
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Two approaches of particular interest to researches 
are pursued for the advancement of the scientific ba-
sis of clinical application, creating new parameters 
for the production of tissues and the development 
of procedures for tissue repair and regeneration in 
vivo, as well2 .
 Bone tissue is constantly in a dynamic morphologi-
cal process following its original formation. Thus, bone 
metabolism is maintained by a constant process of bone 
resorption and formation in response to physical and 
biomechanical changes. This event is controlled by two 
mechanisms: local and systemic regulation, through 
hormones that control the levels of calcium and phos-
phate3,4.5 . Platelet-rich plasma (PRP) is a product of the 
laboratory processing of autologous blood, and its ther-
apeutic strategy is to accelerate wound healing through 
the concentration of growth factors present in platelet 
cytoplasm, which are universal indicators of almost all 
wound healing events6 and free from toxic characteris-
tics or immunoreactivity3.
Studies described in the literature have shown that in 
the fraction of mononuclear cells obtained from bone 
marrow, umbilical cord and other tissues, there are 
both hematopoietic stem cells and mesenchymal stem 
cells7,8. The hematopoietic stem cells give rise to all the 
different cells of the blood, and are characterized by the 
membrane protein CD34.  The mesenchymal stem cells 
give rise to cells that will form the other tissues of the 
body, and they express the membrane markers CD105 
(endoglin) and CD117 (c-kit)9,10,11. Thus, it is possible to 
select the specific cell populations most suitable for the 
regeneration of the tissue of interest.
Material and Method
We used for this study 39 outbred Wistar-Kyoto rats, 
weighing between 200 and 250  g. Six male rats were 
used as bone marrow donors and 33 females rats, used 
for the intervention protocol. The rats were obtained 
from the animal facility of PUCRS; they were housed 
in individual cages and received water and food ad 
libitum. The rats were kept on a 12-h light/dark bio-
logical cycle.
Description of growth factors used in the protocol 
and their origin
a) TGF-β1 - Transforming growth factor beta 1 in 
the protocol. The product was purchased from Bio-
source Laboratory and had a purity of >98%. It was 
reconstituted with sterile distilled water to a con-
centration of 50 mg/mL. We used a concentration of 
6 ng/mL of TGF-β1 in a volume of 30 µL adapted so 
that there was no leakage of fluid in the critical defect 
created12.
b) Isolation of PRP (platelet-rich plasma) from the 
carotid artery of rats via cardiac puncture.
PRP was isolated by cardiac puncture, according to 
the protocol of Plachokova et al.13 and the PRP frac-
tion was purified as described by Rossi Junior, Leme 
and Pispico14. We used 30  µL of PRP in the critical 
defect created15. A hemogram was performed in order 
to determine the number of platelets present in the 
PRP samples from 3 rats used for the treatment proce-
dures. An automated Coulter STKS counter, at Hospi-
tal São Lucas from PUCRS, was used according to the 
manufacturer’s instructions. A 150 uL aliquot of each 
PRP sample was counted and showed the following 
results: animal group 1 - platelets in PRP = 1,650,000 
(1,650 103/uL); animal group 2 - platelets in PRP = 
2,247,000 (2,247 103/uL); animal group 3 - platelets 
in PRP = 2,280,000 (2,280 103/uL).
c) Isolation of mononuclear cells from rat bone 
marrow.
MCs were isolated from the bone marrow donor 
(1 male rat for each study group) after sacrificing 
the animal with intracardiac overdose of thiopental 
(2  mL, equivalent to 100mg /kg rat). The mononu-
clear fraction of bone marrow was obtained by flush-
ing the femurs, tibias, humeri and ulnae of animals. 
We collected the bones, and after they were washed 
with DPBS solution (Gibco®, USA – Invitrogen- São 
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Paulo, SP, Brazil), bone epiphyses were cut. The ex-
traction of bone marrow stroma was obtained by the 
introduction of a 32 G needle in the bone ends, and 
the cavities later washed with heparinized DPBS. The 
content was centrifuged at 1500 rpm and resuspend-
ed in RPMI 1640 (1:1) (Gibco®, USA- Invitrogen-São 
Paulo, SP, Brazil). This suspension was fractionated 
in a density gradient centrifugation using 1.191  g/L 
Histopaque ® (Sigma-Aldrich ®, Saint Louis, Missouri, 
USA) at 400 g for 30 min at 25 °C. The mononuclear 
fraction located at the interface with Histopaque® was 
collected and washed twice with saline. 
Protocol establishing the critical defect
Anesthesia was induced with the animal under re-
straint and in the supine position. Anesthetics were 
administered intraperitoneally using an insulin nee-
dle and syringe.  The rats were given ketamine hy-
drochloride (Ketamin®, Cristália Produtos Químicos 
Farmacêuticos Ltda, Itapira, SP, Brazil) (80 mg/kg 
mouse weight) combined with chlorpromazine hy-
drochloride (Longactil®, Cristália Produtos Quími-
cos Farmacêuticos Ltda, Itapira, SP, Brazil) (2 mg/kg 
mouse weight)16. A 5 mm critical defect was created in 
the femurs bilaterally, following the protocol of Mei-
nel et al.17. The rats used for this study were divided 
into three groups of 11 rats each, where the control 
procedure and treatment were performed in the same 
rat. The animals were under anesthesia, as described 
above, and after confirming the effect of anesthesia, 
the hind legs were shaved. For treatment, animals 
were placed on their side and a transverse incision 
was made, about 2 cm with a Carbon Steel 15 scalpel 
blade (Feather Safety Razor Co. Ltd, Osaka, Japan) on 
the right and left thigh. To expose the femur, the bi-
ceps femoris muscle was retracted posteriorly as the 
gluteus maximus, tensor fascia lata and vastus latera-
lis were retracted anteriorly. We used a retractor to ex-
pose the bone. Next, the periosteum was detached us-
ing a 19cm Freer (Neumar). A long carbide drill, No. 
8, was connected to a high-speed Dental Beltec Mini 
™ motor (NetDental, São Paulo, SP, Brazil) (maximum 
speed of 15,000 rpm drive) to drill the femur while the 
tissue was manually irrigated with saline and drained 
with a Nevoni Vacuum Aspirator ™ (LF Equipamen-
tos, São Paulo, SP, Brazil). The critical defect was in 
the cavity of the medial diaphysis, the between the 
rough line and third trochanter of about 5 mm long by 
2.5 mm wide and deep enough to reach the medullary 
canal17 for application of mononuclear cells and the 
mixture of PRP/TGF-β in the right femur and saline 
in the left femur. Each treatment led to a study group: 
Group 1 - use of MC with 30 µL transforming growth 
factor beta (TGF-β); Group 2 - use of MC with 30 µL 
PRP (platelet-rich plasma); Group 3 - use of MC with 
30 µL transforming growth factor beta (TGF-β) and 
30 µL PRP (platelet-rich plasma).
After that, there was a simple suture with a Mayo-
Hegar Videa tipped needle holder and Ethilon No. 5 
mononylon suture of Ethicon ™ (ISP Dental, São Pau-
lo, SP, Brazil). The suture was performed in compli-
ance with the structure. First was the sternum peri-
osteum, followed by the union of the muscle layers 
and, finally, the skin tissue. The same suture proce-
dure was performed the left side. Postoperatively, in 
the first 24 h, we used as analgesia ketoprofen 5 mg/kg 
subcutaneous18. After 48 h, 200 mg/mL paracetamol 
(Laboratório de Habilidades Cirúrgica PUCRS, Porto 
Alegre, RS, Brazil) was used as analgesia with a dose 
of 1 mL/20mL of H2O, equivalent to a dose of 125 to 
150 mg paracetamol/day.
Radiographic examinations to follow bone growth 
in lesions
To carry out the images, we selected the mammog-
raphy equipment Mamomat 3000 Siemens with FUJI 
CR technology. We used the image transducers Image 
Plate (IP) FUJI specific for mammography. The tech-
nology applied to mammography was selected given 
the size characteristics of the rats and contrast of the 
image for later analysis. An FCR Profect CS FUJI 
reader (model CR-IR 363) was used for image pro-
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cessing. The radiographic technique used consisted 
of a Mo-Mo anode-filter combination at tube acceler-
ating voltage of 28 kVp, and 14 mAs (an appropriate 
technique for imaging the lesion in the femur of these 
animals). The X-ray was taken with each rat placed 
in the central area of irradiation in the ventral decu-
bitus position. After reading the IP, the images were 
saved in dicom format, identifying the group and the 
number of animals in each dataset collection, as well 
as weeks of treatment (the sixth or tenth). According 
with figures 1 and 2.
Euthanasia
The animals were sacrificed 10 weeks after surgi-
cal treatment, following the protocol of Kohn et al.16, 
for later histological analysis. All procedures were 
approved by the Ethics Committee for Animal Use - 
CEUA / PUCRS.
Identification of the DNA of mononuclear cells - 
DNA extraction
DNA extraction was performed with phenol / chlo-
roform based on the method described by Isola et al19.
Molecular analysis– PCR
The cells administered to the lesions were identified 
using the polymerase chain reaction technique (PCR), 
following the protocol described by Mullis et al.20 .
Histochemistry
For histological technique was used the picrosirius 
technique, which is a specific histochemical method 
for the detection of structures composed of oriented 
collagen molecules21. The picrosirius method causes 
large amounts of molecules of Sirius Red with acid 
character and elongated, to be placed in parallel with 
the collagen molecules, which causes considerable 
increase in birefringence of collagen fibers when ob-
served under polarized light22.
The femurs were decalcified with 5% formic acid 
in DPBS. The dehydrated material was embedded in 
paraffin using a Leica TP 1020 tissue processor (Labo-
ratório PUCRS, Porto Alegre, RS, Brazil) The femurs 
were embedded in paraffin and 5μm sections of the 
lesion were made using micrometer Olympus CUT 
4060 (Laboratório PUCRS, Porto Alegre, RS, Brazil). 
The material was placed in an oven at 60  °C over-
night. Afterward, they were deparaffinized (xylene 
2X for 5  min, absolute alcohol - 4X for 2  min) and 
hydrated in water. We then carried out the incubation 
with 1% solution of picrosirius staining for one hour 
followed by washing in running tap water for 20 min. 
The slides were dehydrated and mounted with Can-
ada balsam. The images of histological sections were 
captured by a video camera mounted on an Olympus 
BX40 microscope and analyzed with the aid of the 
software Image Pro-Plus 6.1, as shown in figures 1 
and 2, treated group and control group.
Statistical analysis
The results of the X-ray images were analyzed us-
ing ANOVA (one way). The comparison of the times 
was performed by Student’s t test. The level of signifi-
cance was p <0.05 as statistical difference and statisti-
cal power of 95%. The data were analyzed using SPSS 
14.0. The data analysis for both radiography and his-
tology were entered into a spreadsheet (Microsoft Of-
fice Excel 2003).
Results
Radiographic evaluation
The radiographic evaluation in the postoperative 
period between 6 and 10 weeks showed different re-
sults between the three treatment groups. Group 1, 
MC + TGF-β, showed a reduction rate of 62% better 
in treated than in control. Group 2, MC + PRP, per-
formed better with the rate of reduction being 66% 
greater in treatment than in control. Group 3, MC + 
PRP + TGF-β showed a reduction rate of 66% better 
in control compared to treatment, which indicates 
that this treatment effectively inhibits bone repair. 
The same behavior was observed with the length of 
the lesion where group 1 and 2 had on average 9.8% 
and 12.3% reduction, respectively, while group 3 
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showed 10.6% bone repair in the lesion, when inter-
comparing control with treated bone. The average re-
duction rate for the three groups was approximately 
0.923%, which is not statistically significant between 
the control and treated bone.
Adhesion of mononuclear cells
The presence and subsequent adhesion of mono-
nuclear cells administered to the treated animals was 
determined by PCR using primers complementary to 
the sequence of the marker gene TSPY.
Histological evaluation using picrosirius technique 
The evaluation was made on a sample of animals per 
group at 10 weeks postoperative. The evaluation of his-
tological slides showed new bone formation, with the 
presence of collagen for both the control and treated 
femurs. With the aid of Image-Pro Plus 6.1 (Media Cy-
bernetics, Inc.), the area corresponding to the bone of 
each image was selected. In the bone area of the image, 
with normal bone tissue expressed as 100% neoforma-
tion (ideal) for comparison, we calculated the percent-
age of bone neoformation of the treated area compared 
to normal bone. Based on the number of specimens 
used in this study, the groups tested showed no statis-
tically significant differences in the percentage of new 
bone formation promoted by these treatments com-
pared to control. Histological analysis indicated that 
both the treated group and the control group showed 
collagen neoformation, but there was no difference be-
tween the treatments (p = 0.296).
Discussion
According to Rose and Oreffo1, the Regenerative 
Medicine composes a new field that investigates tis-
sue regeneration techniques from natural markers 
(growth factors) and components of the organism it-
self (stem cells). A femur fracture contributes consid-
erably to morbidity and mortality, especially in older 
patients due to pre-existing diseases and complica-
tions resulting from containment. 
The purpose of this study was to evaluate the thera-
peutic potential of the mononuclear fraction of bone 
marrow cells, as well as the effectiveness of platelet-
rich plasma (PRP) and transforming growth factor 
(TGF-beta) and bone repair.
The animals used in this study, Wistar-Kyoto rats, 
were genetically identical, avoiding any risk of rejec-
tion of the cells used. In our study, the proposed treat-
ments presented different results. Groups 1 and 2, MC 
+ TGF-β and MC + PRP, showed a positive closure of 
the lesion, but there was no indication that one treat-
ment was better than the other. After 6 weeks, a plateau 
is reached with a decrease in new bone formation. In 
group 3, MC + PRP + TGF-β, there was a better closure 
in the control group, i.e., there was a faster rate of re-
duction in tissue damage in the control group. The au-
thors suggested that at 4 weeks the bones treated with 
PRP activated the TGF-β stored in bone compared to 
control for acceleration of osteogenesis. This superna-
tant can be spread around the critical defect treated 
with PRP inhibiting bone repair in the treated bone. 
This would explain why the control had a positive clo-
sure response in relation to the treated bone after 6 and 
10 weeks, when analyzed by X-rays. 
It is imperative, therefore, to establish conditions 
that can regenerate bone tissue in clinical situations 
considered inhospitable, as in places that have com-
promised blood supply in areas of difficult consolida-
tion in regions that have defects with critical dimen-
sions or where the tissue is completely absent.
To evaluate the formation of collagen and show new 
bone formation, were prepared histological slides, 
and images were analyzed in a specific software Im-
age-Pro Plus 6.1. With this program, select the area of 
interest and the program itself made  by counting the 
number of pixel area. The treated area is compared 
with the untreated area (which is defined as 100% 
control of bone formation), adjacent to the treated 
area with a length and width similar to the treatment 
area analyzed in the same histological slide.
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Thus, the results of histological analyzes indicate that 
there was formation of collagen showing new bone for-
mation, both for the treated group as control. However, 
do not indicate that this training may have been influ-
enced by the treatments proposed, there has not submit-
ted seen significant results from the proposed treatment.
Conclusions
a) Bone marrow mononuclear cells did not adhere 
at the critical defect created in the rat femur;
b) It was not possible to determine the efficiency of 
the bone repair treatments studied, as the results did 
not show significant differences between the groups.
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